Particle.news
Download on the App Store

In Space, Phages Evolve Differently, Yielding Variants That Hit Drug-Resistant E. coli

ISS experiments showed an initial infection delay that produced unique receptor-binding changes later tied to broader activity on Earth.

Overview

  • Researchers ran parallel infections of E. coli with T7 phage on the International Space Station and in Earth controls to compare dynamics.
  • Space samples showed no measurable phage growth early on, then successful propagation and bacterial reduction after extended incubation.
  • Whole-genome sequencing and deep mutational scanning revealed distinct mutation patterns in microgravity for both the phage and the bacteria, especially in the T7 receptor-binding protein.
  • Microgravity-selected receptor-binding variants increased activity against certain antibiotic-resistant, UTI-causing E. coli strains that normally resist T7 when tested on Earth.
  • The team links the shifts to reduced fluid mixing, altered encounter rates and changes in host physiology in microgravity, with results published January 13 in PLOS Biology.